Suven Life Sciences

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue5.208.219.448.208.52
Expenses11.8410.4612.3112.9013.29
EBITDA-4.90-0.53-1.16-2.93-3.13
EBIT-6.57-2.20-2.822.80-4.73
Profit Before Tax-6.63-2.25-2.872.76-4.77
Net Profit-6.63-2.25-2.872.76-4.77
Financial Ratios
Operating Profit Margin-163.33%-19.92%-30.26%147.71%-127.76%
Net Profit Margin-221.00%-86.21%-75.53%-153.59%-194.69%
Earning Per Share (Diluted)-0.35-0.05-0.130.13-0.22
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.8
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ